ID   MKRN3_HUMAN             Reviewed;         507 AA.
AC   Q13064;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   10-MAY-2017, entry version 149.
DE   RecName: Full=Probable E3 ubiquitin-protein ligase makorin-3;
DE            EC=2.3.2.27;
DE   AltName: Full=RING finger protein 63;
DE   AltName: Full=RING-type E3 ubiquitin transferase makorin-3 {ECO:0000305};
DE   AltName: Full=Zinc finger protein 127;
GN   Name=MKRN3; Synonyms=D15S9, RNF63, ZNF127;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=10196367; DOI=10.1093/hmg/8.5.783;
RA   Jong M.T.C., Gray T.A., Ji Y., Glenn C.C., Saitoh S., Driscoll D.J.,
RA   Nicholls R.D.;
RT   "A novel imprinted gene, encoding a RING zinc-finger protein, and
RT   overlapping antisense transcript in the Prader-Willi syndrome critical
RT   region.";
RL   Hum. Mol. Genet. 8:783-793(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION.
RX   PubMed=19066619; DOI=10.1038/ejhg.2008.232;
RA   Kanber D., Giltay J., Wieczorek D., Zogel C., Hochstenbach R.,
RA   Caliebe A., Kuechler A., Horsthemke B., Buiting K.;
RT   "A paternal deletion of MKRN3, MAGEL2 and NDN does not result in
RT   Prader-Willi syndrome.";
RL   Eur. J. Hum. Genet. 17:582-590(2009).
RN   [4]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-145 AND THR-239.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [5]
RP   VARIANT CPPB2 SER-365.
RX   PubMed=23738509; DOI=10.1056/NEJMoa1302160;
RA   Abreu A.P., Dauber A., Macedo D.B., Noel S.D., Brito V.N., Gill J.C.,
RA   Cukier P., Thompson I.R., Navarro V.M., Gagliardi P.C., Rodrigues T.,
RA   Kochi C., Longui C.A., Beckers D., de Zegher F., Montenegro L.R.,
RA   Mendonca B.B., Carroll R.S., Hirschhorn J.N., Latronico A.C.,
RA   Kaiser U.B.;
RT   "Central precocious puberty caused by mutations in the imprinted gene
RT   MKRN3.";
RL   N. Engl. J. Med. 368:2467-2475(2013).
RN   [6]
RP   INVOLVEMENT IN CPPB2.
RX   PubMed=25011910; DOI=10.1159/000362815;
RA   Schreiner F., Gohlke B., Hamm M., Korsch E., Woelfle J.;
RT   "MKRN3 mutations in familial central precocious puberty.";
RL   Horm. Res. Paediatr. 82:122-126(2014).
RN   [7]
RP   VARIANT CPPB2 GLN-420.
RX   PubMed=25316453; DOI=10.1093/humrep/deu256;
RA   de Vries L., Gat-Yablonski G., Dror N., Singer A., Phillip M.;
RT   "A novel MKRN3 missense mutation causing familial precocious
RT   puberty.";
RL   Hum. Reprod. 29:2838-2843(2014).
RN   [8]
RP   VARIANT CPPB2 GLY-340.
RX   PubMed=24438377; DOI=10.1210/jc.2013-4084;
RA   Settas N., Dacou-Voutetakis C., Karantza M., Kanaka-Gantenbein C.,
RA   Chrousos G.P., Voutetakis A.;
RT   "Central precocious puberty in a girl and early puberty in her brother
RT   caused by a novel mutation in the MKRN3 gene.";
RL   J. Clin. Endocrinol. Metab. 99:E647-651(2014).
RN   [9]
RP   VARIANT CPPB2 ILE-417.
RX   PubMed=24628548; DOI=10.1210/jc.2013-3126;
RA   Macedo D.B., Abreu A.P., Reis A.C., Montenegro L.R., Dauber A.,
RA   Beneduzzi D., Cukier P., Silveira L.F., Teles M.G., Carroll R.S.,
RA   Junior G.G., Filho G.G., Gucev Z., Arnhold I.J., de Castro M.,
RA   Moreira A.C., Martinelli C.E. Jr., Hirschhorn J.N., Mendonca B.B.,
RA   Brito V.N., Antonini S.R., Kaiser U.B., Latronico A.C.;
RT   "Central precocious puberty that appears to be sporadic caused by
RT   paternally inherited mutations in the imprinted gene makorin ring
RT   finger 3.";
RL   J. Clin. Endocrinol. Metab. 99:E1097-1103(2014).
CC   -!- FUNCTION: E3 ubiquitin ligase catalyzing the covalent attachment
CC       of ubiquitin moieties onto substrate proteins. {ECO:0000250,
CC       ECO:0000269|PubMed:19066619}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-2340269, EBI-2340269;
CC       Q08117-2:AES; NbExp=6; IntAct=EBI-2340269, EBI-11741437;
CC       Q9BXY8:BEX2; NbExp=5; IntAct=EBI-2340269, EBI-745073;
CC       Q9BSW2:CRACR2A; NbExp=3; IntAct=EBI-2340269, EBI-739773;
CC       Q9H0I2:ENKD1; NbExp=4; IntAct=EBI-2340269, EBI-744099;
CC       P07992:ERCC1; NbExp=3; IntAct=EBI-2340269, EBI-750962;
CC       Q9BQ89:FAM110A; NbExp=5; IntAct=EBI-2340269, EBI-1752811;
CC       Q9H5Z6:FAM124B; NbExp=3; IntAct=EBI-2340269, EBI-741626;
CC       O95363:FARS2; NbExp=3; IntAct=EBI-2340269, EBI-2513774;
CC       O15151:MDM4; NbExp=6; IntAct=EBI-2340269, EBI-398437;
CC       P82932:MRPS6; NbExp=3; IntAct=EBI-2340269, EBI-716172;
CC       Q96AH0:NABP1; NbExp=3; IntAct=EBI-2340269, EBI-2889252;
CC       O15160:POLR1C; NbExp=4; IntAct=EBI-2340269, EBI-1055079;
CC       F1T0A5:PRPF31; NbExp=3; IntAct=EBI-2340269, EBI-10177194;
CC       Q8WWY3:PRPF31; NbExp=7; IntAct=EBI-2340269, EBI-1567797;
CC       P25786:PSMA1; NbExp=5; IntAct=EBI-2340269, EBI-359352;
CC       Q96IZ5:RBM41; NbExp=3; IntAct=EBI-2340269, EBI-740773;
CC       Q9BWG6:SCNM1; NbExp=5; IntAct=EBI-2340269, EBI-748391;
CC       Q15637:SF1; NbExp=3; IntAct=EBI-2340269, EBI-744603;
CC       P31947:SFN; NbExp=3; IntAct=EBI-2340269, EBI-476295;
CC       Q15560:TCEA2; NbExp=3; IntAct=EBI-2340269, EBI-710310;
CC       Q9BT92:TCHP; NbExp=5; IntAct=EBI-2340269, EBI-740781;
CC       P05549:TFAP2A; NbExp=3; IntAct=EBI-2340269, EBI-347351;
CC       Q96NG3:TTC25; NbExp=3; IntAct=EBI-2340269, EBI-1046387;
CC       P51668:UBE2D1; NbExp=4; IntAct=EBI-2340269, EBI-743540;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10196367}.
CC   -!- DISEASE: Precocious puberty, central 2 (CPPB2) [MIM:615346]: A
CC       condition defined as the development of secondary sexual
CC       characteristics in boys and girls at a chronological age that is
CC       2.5 standard deviations below the mean age at onset of puberty in
CC       the population. Central precocious puberty results from premature
CC       activation of the hypothalamic-pituitary-gonadal axis.
CC       {ECO:0000269|PubMed:23738509, ECO:0000269|PubMed:24438377,
CC       ECO:0000269|PubMed:24628548, ECO:0000269|PubMed:25011910,
CC       ECO:0000269|PubMed:25316453}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Imprinted, expressed from the paternal chromosome
CC       only. A deficiency of MKRN3 is not sufficient to cause Prader-
CC       Willi syndrome (PWS).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U19107; AAC13989.1; -; Genomic_DNA.
DR   EMBL; BC044639; AAH44639.1; -; mRNA.
DR   CCDS; CCDS10013.1; -.
DR   PIR; G01614; G01614.
DR   RefSeq; NP_005655.1; NM_005664.3.
DR   UniGene; Hs.679587; -.
DR   UniGene; Hs.72964; -.
DR   ProteinModelPortal; Q13064; -.
DR   SMR; Q13064; -.
DR   BioGrid; 113479; 57.
DR   IntAct; Q13064; 156.
DR   STRING; 9606.ENSP00000313881; -.
DR   iPTMnet; Q13064; -.
DR   PhosphoSitePlus; Q13064; -.
DR   BioMuta; MKRN3; -.
DR   DMDM; 17368438; -.
DR   EPD; Q13064; -.
DR   MaxQB; Q13064; -.
DR   PaxDb; Q13064; -.
DR   PeptideAtlas; Q13064; -.
DR   PRIDE; Q13064; -.
DR   DNASU; 7681; -.
DR   Ensembl; ENST00000314520; ENSP00000313881; ENSG00000179455.
DR   GeneID; 7681; -.
DR   KEGG; hsa:7681; -.
DR   UCSC; uc001ywh.5; human.
DR   CTD; 7681; -.
DR   DisGeNET; 7681; -.
DR   GeneCards; MKRN3; -.
DR   GeneReviews; MKRN3; -.
DR   HGNC; HGNC:7114; MKRN3.
DR   HPA; HPA029494; -.
DR   MalaCards; MKRN3; -.
DR   MIM; 603856; gene.
DR   MIM; 615346; phenotype.
DR   neXtProt; NX_Q13064; -.
DR   OpenTargets; ENSG00000179455; -.
DR   Orphanet; 169615; Idiopathic central precocious puberty.
DR   PharmGKB; PA30833; -.
DR   eggNOG; KOG1039; Eukaryota.
DR   eggNOG; ENOG410XRM0; LUCA.
DR   GeneTree; ENSGT00390000014093; -.
DR   HOGENOM; HOG000252976; -.
DR   HOVERGEN; HBG066965; -.
DR   InParanoid; Q13064; -.
DR   KO; K15687; -.
DR   OMA; QCKEGEN; -.
DR   OrthoDB; EOG091G07DG; -.
DR   PhylomeDB; Q13064; -.
DR   TreeFam; TF315108; -.
DR   UniPathway; UPA00143; -.
DR   GenomeRNAi; 7681; -.
DR   PRO; PR:Q13064; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000179455; -.
DR   CleanEx; HS_MKRN3; -.
DR   ExpressionAtlas; Q13064; baseline and differential.
DR   Genevisible; Q13064; HS.
DR   GO; GO:0030529; C:intracellular ribonucleoprotein complex; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0016740; F:transferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR026294; Makorin_3.
DR   InterPro; IPR031644; MKRN1_C.
DR   InterPro; IPR018957; Znf_C3HC4_RING-type.
DR   InterPro; IPR000571; Znf_CCCH.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR11224:SF47; PTHR11224:SF47; 1.
DR   Pfam; PF15815; MKRN1_C; 1.
DR   Pfam; PF00097; zf-C3HC4; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00356; ZnF_C3H1; 3.
DR   SUPFAM; SSF90229; SSF90229; 1.
DR   PROSITE; PS50103; ZF_C3H1; 3.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disease mutation; Metal-binding; Polymorphism;
KW   Reference proteome; Repeat; Transferase; Ubl conjugation pathway;
KW   Zinc; Zinc-finger.
FT   CHAIN         1    507       Probable E3 ubiquitin-protein ligase
FT                                makorin-3.
FT                                /FTId=PRO_0000055959.
FT   ZN_FING      95    122       C3H1-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00723}.
FT   ZN_FING     238    265       C3H1-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00723}.
FT   ZN_FING     311    365       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   ZN_FING     394    423       C3H1-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00723}.
FT   REGION      266    293       Makorin-type Cys-His.
FT   VARIANT     145    145       T -> M (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs371642799).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035955.
FT   VARIANT     239    239       S -> T (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035956.
FT   VARIANT     340    340       C -> G (in CPPB2).
FT                                {ECO:0000269|PubMed:24438377}.
FT                                /FTId=VAR_073023.
FT   VARIANT     365    365       R -> S (in CPPB2).
FT                                {ECO:0000269|PubMed:23738509}.
FT                                /FTId=VAR_070103.
FT   VARIANT     417    417       F -> I (in CPPB2).
FT                                {ECO:0000269|PubMed:24628548}.
FT                                /FTId=VAR_073024.
FT   VARIANT     420    420       H -> Q (in CPPB2; dbSNP:rs755791221).
FT                                {ECO:0000269|PubMed:25316453}.
FT                                /FTId=VAR_073025.
SQ   SEQUENCE   507 AA;  55645 MW;  2EDBA91190F3A292 CRC64;
     MEEPAAPSEA HEAAGAQAGA EAAREGVSGP DLPVCEPSGE SAAPDSALPH AARGWAPFPV
     APVPAHLRRG GLRPAPASGG GAWPSPLPSR SSGIWTKQII CRYYIHGQCK EGENCRYSHD
     LSGRKMATEG GVSPPGASAG GGPSTAAHIE PPTQEVAEAP PAASSLSLPV IGSAAERGFF
     EAERDNADRG AAGGAGVESW ADAIEFVPGQ PYRGRWVASA PEAPLQSSET ERKQMAVGSG
     LRFCYYASRG VCFRGESCMY LHGDICDMCG LQTLHPMDAA QREEHMRACI EAHEKDMELS
     FAVQRGMDKV CGICMEVVYE KANPNDRRFG ILSNCNHSFC IRCIRRWRSA RQFENRIVKS
     CPQCRVTSEL VIPSEFWVEE EEEKQKLIQQ YKEAMSNKAC RYFAEGRGNC PFGDTCFYKH
     EYPEGWGDEP PGPGGGSFSA YWHQLVEPVR MGEGNMLYKS IKKELVVLRL ASLLFKRFLS
     LRDELPFSED QWDLLHYELE EYFNLIL
//
